Triflusal is a platelet aggregation inhibitor derived from acetylsalicylic acid, with a trifluoromethyl group replacing a hydrogen atom on the benzene ring. It is used as an active pharmaceutical ingredient in manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 322-79-2
Prasugrel
platelet aggregation inhibitor
Eptifibatide
pharmaceutical raw material
Calcitriol
pharmaceutical raw material
Melphalan hydrochloride
pharmaceutical raw material
Ornithine aspartate
pharmaceutical raw material
N6-Hydroxymethyl Adefovir Dipivoxil
pharmaceutical raw material
2-acetyloxy-4-(trifluoromethyl)benzoic acid
RMWVZGDJPAKBDE-UHFFFAOYSA-N
CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O